RETEVMO 40 MG Israel - English - Ministry of Health

retevmo 40 mg

eli lilly israel ltd, israel - selpercatinib - capsules - selpercatinib 40 mg - selpercatinib - • metastatic ret fusion-positive non-small cell lung cancerretevmo™ is indicated for the treatment of adult patients with metastatic ret fusion-positive non-small cell lung cancer (nsclc).• ret-mutant medullary thyroid cancerretevmo is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic ret-mutant medullary thyroid cancer (mtc) who require systemic therapy.• ret fusion-positive thyroid cancerretevmo is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic ret fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).

RETEVMO 80 MG Israel - English - Ministry of Health

retevmo 80 mg

eli lilly israel ltd, israel - selpercatinib - capsules - selpercatinib 80 mg - selpercatinib - • metastatic ret fusion-positive non-small cell lung cancerretevmo™ is indicated for the treatment of adult patients with metastatic ret fusion-positive non-small cell lung cancer (nsclc).• ret-mutant medullary thyroid cancerretevmo is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic ret-mutant medullary thyroid cancer (mtc) who require systemic therapy.• ret fusion-positive thyroid cancerretevmo is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic ret fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).

MOUNJARO 10 MG0.5 ML Israel - English - Ministry of Health

mounjaro 10 mg0.5 ml

eli lilly israel ltd, israel - tirzepatide - solution for injection - tirzepatide 20 mg/ml - tirzepatide - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.

MOUNJARO 12.5 MG0.5 ML Israel - English - Ministry of Health

mounjaro 12.5 mg0.5 ml

eli lilly israel ltd, israel - tirzepatide - solution for injection - tirzepatide 25 mg/ml - tirzepatide - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.

MOUNJARO 15 MG0.5 ML Israel - English - Ministry of Health

mounjaro 15 mg0.5 ml

eli lilly israel ltd, israel - tirzepatide - solution for injection - tirzepatide 30 mg/ml - tirzepatide - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.

MOUNJARO 2.5 MG0.5 ML Israel - English - Ministry of Health

mounjaro 2.5 mg0.5 ml

eli lilly israel ltd, israel - tirzepatide - solution for injection - tirzepatide 5 mg/ml - tirzepatide - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.

MOUNJARO 5 MG0.5 ML Israel - English - Ministry of Health

mounjaro 5 mg0.5 ml

eli lilly israel ltd, israel - tirzepatide - solution for injection - tirzepatide 10 mg/ml - tirzepatide - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.

MOUNJARO 7.5 MG0.5 ML Israel - English - Ministry of Health

mounjaro 7.5 mg0.5 ml

eli lilly israel ltd, israel - tirzepatide - solution for injection - tirzepatide 15 mg/ml - tirzepatide - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.

CYMBALTA 30 MG Israel - English - Ministry of Health

cymbalta 30 mg

eli lilly israel ltd, israel - duloxetine as hydrochloride - gastro resistant capsules - duloxetine as hydrochloride 30 mg - duloxetine - cymbalta is indicated for the treatment of major depressive episodes.- cymbalta is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy.- cymbalta is indicated for the treatment of generalized anxiety disorder (gad).- cymbalta is indicated for the management of fibromyalgia.- cymbalta is indicated for the management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. this has been established in studies in patients with chronic low back pain (clbp) and chronic pain due to osteoarthritis.

CYMBALTA 60 MG Israel - English - Ministry of Health

cymbalta 60 mg

eli lilly israel ltd, israel - duloxetine as hydrochloride - gastro resistant capsules - duloxetine as hydrochloride 60 mg - duloxetine - cymbalta is indicated for the treatment of major depressive episodes.- cymbalta is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy.- cymbalta is indicated for the treatment of generalized anxiety disorder (gad).- cymbalta is indicated for the management of fibromyalgia.- cymbalta is indicated for the management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. this has been established in studies in patients with chronic low back pain (clbp) and chronic pain due to osteoarthritis.